Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

SunTrust Banks, Inc. (STI) Dips On Earnings Beat; Is Now The Time To Buy?

Page 1 of 2

SunTrust Banks, Inc. (NYSE:STI) has added itself to the list of companies that are posting better-than-expected quarterly results this reporting season. The financial institution reported earnings per share of $0.89 over revenues of $2.08 billion for the second quarter of 2015 this morning. Wall Street had estimated earnings per share of $0.81 and revenues of $2.02 billion. The bank recorded growth of $0.17 or 24% in earnings per share compared to the prior year, while its revenue dipped by 6% on a year-over-year basis. Nonetheless, shares of SunTrust Banks, Inc. (NYSE:STI) are trading down by 2.01% in early afternoon trading.

William H. Rogers, Jr., chairman and CEO of SunTrust Banks, Inc, said, “Our performance this quarter demonstrates solid execution of our key strategies – deepening client relationships, optimizing the balance sheet, and improving efficiency. This was evidenced by higher revenue, continued deposit growth, and improved returns.  In addition, our asset quality performance continues to be strong.” In spite of growth in its earnings per share, SunTrust Banks, Inc. (NYSE:STI) witnessed a drop of 8% in its net interest margin year-over-year, which came in at 2.86% during the quarter, though it was an increase from 2.83% quarter-over-quarter. The metric is a key measurement to judge the profitability of banks. Another is the bank’s efficiency ratio, which was lowered to 63.4% from 63.6% year-over-year. SunTrust executives are aiming to bring it below 63% this year.

SunTrust Banks, Inc. (NYSE:STI)

The hedge funds tracked by Insider Monkey had a positive outlook of the banking firm during the first quarter, as 34 hedge fund managers had investments of $348.01 million in the company compared to aggregate holdings of $299.58 million from 29 hedge fund managers to start the quarter. It is important to consider that the hedge fund managers increased their investments in the company despite a 1.93% drop in its share prices during the first quarter. Shares are up by 8.2% since then.

At Insider Monkey, we track hedge funds’ moves in order to identify actionable patterns and profit from them. Our research has shown that hedge funds’ large-cap stock picks historically delivered a monthly alpha of six basis points, though these stocks underperformed the S&P 500 Total Return Index by an average of seven basis points per month between 1999 and 2012. On the other hand, the 15 most popular small-cap stocks among hedge funds outperformed the S&P 500 Index by an average of 95 basis points per month (read the details here). Since the official launch of our small-cap strategy in August 2012, it has performed just as predicted, returning over 139% and beating the market by more than 80 percentage points. We believe the data is clear: investors will be better off by focusing on small-cap stocks utilizing hedge fund expertise rather than large-cap stocks.

We also track insider activity, of which there were 13 insider sales at SunTrust in 2015. Raymond D. Fortin, Corporate Executive Vice President and General Counsel of Suntrust Banks Inc, sold 156,469 shares of the bank in 2015, including the recent sale of 39,240 shares on May 19.

Considering the positive hedge fund sentiment surrounding the company, we’re going to check out the key action regarding SunTrust Banks, Inc. (NYSE:STI).

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!